News Releases News Releases HOME HOME

September 5, 2000

Company Name Taisho Pharmaceutical Co., Ltd.
Head Office 3-24-1 Takada, Toshima-ku, Tokyo
Representative Director
(name and title)
Akira Uehara, President (First Section of the Tokyo Stock Exchange: Ticker Code 4535)
Management Contact Takayuki Kagami, Accounting Division Trustee
TEL 81-3-3985-1111 (switchboard)

Notification of the Purchase of Treasury Stock

Details of the treasury stock purchase announced yesterday (September 4, 2000) are provided below.

1. Reason for purchase
Retirement of stock in accordance with Section 3 of the Commercial Code governing the retirement of shares

2. Type of stock purchased
Taisho par-value common stock

3. Amount of stock purchased

4. Price
3,190 yen

5. Date of transaction
Tuesday, September 5, 2000

6. Method of purchase
Purchased at closing price from ToSTNeT-2 of the Tokyo Stock Exchange

We are pleased to announce that this treasury stock purchase was completed as resolved by the Board of Directors on September 4, 2000.